CN104768566B - 胶原水解物及其用途 - Google Patents

胶原水解物及其用途 Download PDF

Info

Publication number
CN104768566B
CN104768566B CN201380057628.9A CN201380057628A CN104768566B CN 104768566 B CN104768566 B CN 104768566B CN 201380057628 A CN201380057628 A CN 201380057628A CN 104768566 B CN104768566 B CN 104768566B
Authority
CN
China
Prior art keywords
collagen
use according
collagen hydrolyzate
weight
hydrolyzate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201380057628.9A
Other languages
English (en)
Chinese (zh)
Other versions
CN104768566A (zh
Inventor
斯特芬·奥瑟尔
莫尼卡·吉森-维泽尔
汉斯-乌尔里希·弗雷希
斯特凡·豪斯曼斯
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Galida Co Ltd
Original Assignee
Gelita AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=49578271&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CN104768566(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Gelita AG filed Critical Gelita AG
Publication of CN104768566A publication Critical patent/CN104768566A/zh
Application granted granted Critical
Publication of CN104768566B publication Critical patent/CN104768566B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J3/00—Working-up of proteins for foodstuffs
    • A23J3/30—Working-up of proteins for foodstuffs by hydrolysis
    • A23J3/32—Working-up of proteins for foodstuffs by hydrolysis using chemical agents
    • A23J3/34—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes
    • A23J3/341—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of animal proteins
    • A23J3/342—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of animal proteins of collagen; of gelatin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
    • A61K38/014—Hydrolysed proteins; Derivatives thereof from animals from connective tissue peptides, e.g. gelatin, collagen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Nutrition Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Toxicology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
CN201380057628.9A 2012-11-06 2013-11-04 胶原水解物及其用途 Active CN104768566B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102012110612.6A DE102012110612A1 (de) 2012-11-06 2012-11-06 Kollagenhydrolysat und dessen Verwendung
DE102012110612.6 2012-11-06
PCT/EP2013/072894 WO2014072235A1 (de) 2012-11-06 2013-11-04 Kollagenhydrolysat und dessen verwendung

Publications (2)

Publication Number Publication Date
CN104768566A CN104768566A (zh) 2015-07-08
CN104768566B true CN104768566B (zh) 2018-06-29

Family

ID=49578271

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201380057628.9A Active CN104768566B (zh) 2012-11-06 2013-11-04 胶原水解物及其用途

Country Status (13)

Country Link
US (1) US10364283B2 (https=)
EP (1) EP2916855B1 (https=)
JP (1) JP6272891B2 (https=)
CN (1) CN104768566B (https=)
AU (1) AU2013343685B2 (https=)
BR (1) BR112015009473B1 (https=)
CL (1) CL2015001159A1 (https=)
DE (1) DE102012110612A1 (https=)
ES (1) ES2587928T3 (https=)
MX (1) MX2015005649A (https=)
PL (1) PL2916855T3 (https=)
RU (1) RU2671401C2 (https=)
WO (1) WO2014072235A1 (https=)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102013104897A1 (de) 2013-05-13 2014-11-13 Gelita Ag Wirkstoff zur Behandlung von Sarkopenie
DE102014117036A1 (de) 2014-11-20 2016-05-25 RenaCare NEPHROMED GmbH Zusammensetzung zur Eiweißsubstitution
DE202014105602U1 (de) 2014-11-20 2015-11-23 RenaCare NEPHROMED GmbH Zusammensetzung zur Eiweißsubstitution
RU2659383C2 (ru) * 2015-10-20 2018-06-29 федеральное государственное автономное образовательное учреждение высшего образования "Казанский (Приволжский) федеральный университет" (ФГАОУ ВО КФУ) Биоактивный гидрогель для регенерации кожи
DE102015121923A1 (de) * 2015-12-16 2017-06-22 Gelita Ag Gießmasse und Verfahren für die Herstellung von Gelatineprodukten
GR1009140B (el) * 2016-01-12 2017-10-20 Σωτηρης Γεωργιου Χορτομαρης Συμπληρωμα διατροφης με χοιρινο και βοϊο κολλαγονο υδρολυμενο και ζελατινη
EP3411016B1 (en) 2016-02-03 2024-09-11 Fresenius Kabi Deutschland GmbH High caloric, high protein nutritional formula
NL2017219B1 (en) * 2016-07-22 2018-01-30 Rousselot B V Low cross-linking gelatine
US11110147B2 (en) * 2017-03-15 2021-09-07 Rousselot B.V Collagen hydrolysates as a beneficial prebiotic and their effect on joint inflammation and osteoarthritis
CN107083415A (zh) * 2017-05-27 2017-08-22 四川汇宇生物技术有限公司 一种明胶的生产方法
US11998654B2 (en) 2018-07-12 2024-06-04 Bard Shannon Limited Securing implants and medical devices
DE102018120420A1 (de) * 2018-08-22 2020-02-27 Gelita Ag Proteinriegel
DE102019202606A1 (de) * 2018-11-06 2020-05-07 Gelita Ag Rekombinante Herstellung eines Kollagenpeptidpräparates und dessen Verwendung
DE102019207859A1 (de) 2018-12-21 2020-06-25 Gelita Ag Synthetische und rekombinant hergestellte Kollagenpeptide mit biologischer Wirksamkeit
DE102020210725A1 (de) 2019-10-31 2021-05-06 Gelita Ag Ernährungsphysiologisch optimiertes Kollagenpeptid
DE102019130196A1 (de) * 2019-11-08 2021-05-12 Gelita Ag Verfahren zur Herstellung von Kollagenpeptiden aus Knochen, und hergestellte Kollagenpeptide
DE102019130197A1 (de) * 2019-11-08 2021-05-12 Gelita Ag Verfahren zur Herstellung von Knochengelatine, und hergestellte Knochengelatine
US20210145764A1 (en) * 2019-11-15 2021-05-20 Brigham Young University Compositions of cannabidiol (cbd), and/or polyphenols, and methods for the prevention and/or treatment of skin, muscle, nerve and inflammatory disorders, and biological factors and functions in mammals
CA3164511A1 (en) 2020-01-13 2021-07-22 Chathurada GAJADEERA Turkey collagen hydrolysates and methods of making
DE102020126594A1 (de) * 2020-10-09 2022-04-14 Gelita Ag Kollagenhydrolysat als Wirkstoff zum Verzögern der Alterung
JP7631623B2 (ja) * 2022-08-31 2025-02-18 ルースロ ビーヴイ 集中治療後症候群（ｐｉｃｓ）の予防及び／又は治療に使用するためのコラーゲン加水分解物
DE202023107635U1 (de) 2023-12-22 2024-02-08 RenaCare NEPHROMED GmbH Zusammensetzung zur Eiweißsubstitution
CN120060939B (zh) * 2025-01-26 2025-12-02 大连理工大学 一种纳米孪晶铜电镀添加剂及电镀液

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101568552A (zh) * 2006-11-15 2009-10-28 明治制果株式会社 胶原肽组合物以及含有其的饮食品
WO2012065782A2 (de) * 2010-11-15 2012-05-24 Gelita Ag Kollagenhydrolysat für die verwendung zur verbesserung der gesundheit der menschlichen haut, haare und/oder nägel
WO2012117012A1 (de) * 2011-03-01 2012-09-07 Gelita Ag Zusammensetzung für ernährungszwecke

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5120761A (en) * 1988-10-14 1992-06-09 Finnan Jeffrey L Method of making a free-flowing spray dried edible powder comprising an oil
JP2859343B2 (ja) * 1988-10-14 1999-02-17 ビーエーエスエフ、コーポレーション 油を含んで成る自由流動性噴霧乾燥食用粉末の製造法
AU699192B2 (en) * 1993-08-13 1998-11-26 Bayer Corporation Hydrolyzed gelatin as a flavor enhancer in a chewable tablet
FR2720067B1 (fr) 1994-05-17 1996-08-02 Dielen Lab Hydrolysat de protéines d'animaux marins, procédé d'obtention et applications.
EP0777491B1 (de) 1994-08-23 2004-11-17 Deutsche Gelatine-Fabriken Stoess AG Verwendung von geschmacksneutralem, hydrolysiertem kollagen und mittel enthaltend dasselbe
JP4609807B2 (ja) 1996-03-28 2011-01-12 雪印乳業株式会社 骨強化用医薬、飲食品及び飼料
JPH1112192A (ja) * 1997-06-18 1999-01-19 Zenyaku Kogyo Kk 骨粗鬆症予防・治療剤
US20020025921A1 (en) * 1999-07-26 2002-02-28 Petito George D. Composition and method for growing, protecting, and healing tissues and cells
GB0031065D0 (en) * 2000-12-20 2001-01-31 Univ Cardiff Preservation of cells
GB2418431A (en) * 2004-09-27 2006-03-29 Multigerm Uk Entpr Ltd Metabolically active micro organisms and methods for their production
US7485323B2 (en) * 2005-05-31 2009-02-03 Gelita Ag Process for making a low molecular weight gelatine hydrolysate and gelatine hydrolysate compositions
WO2007044945A2 (en) 2005-10-13 2007-04-19 Gu, Jennifer, L. Mineral collagen chelates and methods of making and using same
US20120142598A1 (en) * 2006-12-18 2012-06-07 Zeev Pam Edible compositions for preventing hair loss
JP2008247809A (ja) 2007-03-30 2008-10-16 Yaizu Suisankagaku Industry Co Ltd コラーゲン錠剤
FR2927336B1 (fr) * 2008-02-12 2010-05-21 Cie Des Peches Saint Malo Sant Hydrolysat de proteines de poissons presentant une activite de stimulation et de maintien du capital osseux, compositions nutraceutiques et pharmacologiques comprenant un tel hydrolysat et procede d'obtention
DE102009030351A1 (de) 2009-06-22 2010-12-23 Gelita Ag Zusammensetzung zur Behandlung von degenerativen Gelenkerkrankungen
CN102094056B (zh) 2009-12-14 2013-04-03 包头东宝生物技术股份有限公司 可溶性胶原蛋白的制备方法
JP5370225B2 (ja) * 2010-03-18 2013-12-18 株式会社デンソーウェーブ ロボットのアーム連結装置
US8603183B2 (en) * 2011-06-22 2013-12-10 Shinn Jyh Ding Bilayered bone graft device

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101568552A (zh) * 2006-11-15 2009-10-28 明治制果株式会社 胶原肽组合物以及含有其的饮食品
WO2012065782A2 (de) * 2010-11-15 2012-05-24 Gelita Ag Kollagenhydrolysat für die verwendung zur verbesserung der gesundheit der menschlichen haut, haare und/oder nägel
WO2012117012A1 (de) * 2011-03-01 2012-09-07 Gelita Ag Zusammensetzung für ernährungszwecke

Also Published As

Publication number Publication date
EP2916855A1 (de) 2015-09-16
EP2916855B1 (de) 2016-07-27
AU2013343685A1 (en) 2015-05-21
DE102012110612A1 (de) 2014-05-08
US20150232534A1 (en) 2015-08-20
CN104768566A (zh) 2015-07-08
AU2013343685B2 (en) 2018-03-29
AU2013343685A8 (en) 2015-07-02
JP2015534812A (ja) 2015-12-07
US10364283B2 (en) 2019-07-30
BR112015009473A2 (pt) 2017-07-04
PL2916855T3 (pl) 2017-08-31
RU2015121573A (ru) 2016-12-27
BR112015009473B1 (pt) 2022-10-04
WO2014072235A1 (de) 2014-05-15
JP6272891B2 (ja) 2018-01-31
CL2015001159A1 (es) 2015-08-28
RU2671401C2 (ru) 2018-10-31
MX2015005649A (es) 2015-08-20
ES2587928T3 (es) 2016-10-27

Similar Documents

Publication Publication Date Title
CN104768566B (zh) 胶原水解物及其用途
CA2286552C (en) Aminosugar, glycosaminoglycan or glycosaminoglycan-like compounds, and s-adenosylmethionine
JP6133217B2 (ja) 食塊の安全な嚥下を促進するための伸長粘度
US20130345139A1 (en) Composition for nutrition purposes
EP2012818B1 (en) Hydrolysate of avian cartilage, process of preparation and uses thereof
JP6441825B2 (ja) フィラーの効能維持用組成物
TWI722983B (zh) 含有膠原蛋白肽之組成物的苦味掩蔽方法
CN104939054A (zh) 一种增强骨密度及免疫力的保健食品及其制备方法
CN115702687A (zh) 一种胶原蛋白肽透明质酸钠氨基酸组合物的制备与应用
US20200046772A1 (en) Cartilage regeneration-promoting agent
EP2210507B1 (en) Bone-strengthening compositions
CN101861332B (zh) 用于促进成骨细胞分化和抑制破骨细胞分化的食品原材料
WO1994003203A1 (fr) Activateur des cellules du tube digestif
JP2006166807A (ja) 健康美容食品
Yamada et al. Study of the cartilage matrix production-promoting effect of chicken leg extract and identification of the active ingredient
US20210401020A1 (en) Hafnia alvei formulations
CN115192602B (zh) 一种复合益生元及其在调节肠道功能中的应用
RU2552444C1 (ru) Композиция продукта с биологически активными свойствами
CN111012900B (zh) 一种具有增加骨密度功能的组合物及其制备方法与应用
CN103494201B (zh) L-抗坏血酸棕榈酸酯配伍的骨关节疾病保健品
JP2020200288A (ja) 変形性関節症予防又は改善剤
TWI686204B (zh) 源自乳汁之鹼性蛋白質級分及/或源自乳汁之鹼性蛋白質級分分解物、與乳清蛋白質水解物之用途
CN108902987A (zh) 乳矿物盐氨糖软骨素维d胶囊
JP2020110066A (ja) コンドロイチン硫酸含有ブタ軟骨抽出物を有効成分とする血圧上昇抑制剤およびそれを含有する食品組成物
HK1197366B (zh) 填充剂的效能维持用组合物

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
CP01 Change in the name or title of a patent holder

Address after: German E Bo Bach

Patentee after: Galida Co., Ltd.

Address before: German E Bo Bach

Patentee before: Gelita AG

CP01 Change in the name or title of a patent holder